Page last updated: 2024-11-05

triazolam and Gas Gangrene

triazolam has been researched along with Gas Gangrene in 1 studies

Triazolam: A short-acting benzodiazepine used in the treatment of insomnia. Some countries temporarily withdrew triazolam from the market because of concerns about adverse reactions, mostly psychological, associated with higher dose ranges. Its use at lower doses with appropriate care and labeling has been reaffirmed by the FDA and most other countries.

Gas Gangrene: A severe condition resulting from bacteria invading healthy muscle from adjacent traumatized muscle or soft tissue. The infection originates in a wound contaminated with bacteria of the genus CLOSTRIDIUM. C. perfringens accounts for the majority of cases (over eighty percent), while C. noyvi, C. septicum, and C. histolyticum cause most of the other cases.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Haiart, DC1
Andrade, B1
Murie, JA1

Other Studies

1 other study available for triazolam and Gas Gangrene

ArticleYear
Gas gangrene following intra-arterial injection of oral medication in a drug abuser.
    European journal of vascular surgery, 1992, Volume: 6, Issue:5

    Topics: Accidents; Adult; Animals; Cyclizine; Femoral Artery; Gas Gangrene; Humans; Injections, Intra-Arteri

1992
chemdatabank.com